MDT
Medtronic PLC
ACTIONABLEMethodology gates passed
Position levels
Currenttoday
USD 91.23
Buy <=wait / entry
USD 84.00
Trim >=take some off
USD 96.00
Thesis breakTwo consecutive quarters of organic revenue growth below 4% combined with a fres...
-
Scenario-weighted conviction
| Probability | Score | Contribution | |
|---|---|---|---|
| Bull case | 37% | 100 / 100 | 37.0 |
| Base case | 47% | 62 / 100 | 29.1 |
| Bear case | 16% | 10 / 100 | 1.6 |
| Weighted conviction | 68 / 100 - BUY | ||
Top risks
- M&A activity: Medtronic completes acquisition of Scientia Vascular, integrating access and therapeutic portfolios for neurovascular care
- Earnings performance: Q4 2026 revenue of $9.8 billion increased 9.9% reported and 6.6% organic, with non-GAAP EPS of $1.55 meeting expectations
- Segment momentum: Cardiac Ablation Solutions revenue increased 78% globally including 124% U.S. growth, gaining 8 points of U.S. share